image
Kymera Therapeutics, Inc. KYMR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 41.96
-8.67 %
$ 2.72 B
Market Cap
-19.61
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 67.84% 3.21% -2.65%
Annual Report FY 10-K 2022-12-31 -35.71% -54.94% -60.41%
Annual Report FY 10-K 2021-12-31 114.00% -122.99% -117.11%
Annual Report FY 10-K 2020-12-31 1059.99% -6.42% -9.71%
Annual Report FY 10-K 2019-12-31 0.00% -92.35% -96.75%
Annual Report FY 10-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -20.88% -18.20% -25.41%
Quarterly Report Q2 8-K 2024-06-30 55.33% -8.41% -17.38%
Quarterly Report Q1 8-K 2024-03-31 8.67% -32.72% -16.72%
Quarterly Report Q4 8-K 2023-12-31 196.70% 57.80% 50.01%
Quarterly Report Q3 8-K 2023-09-30 -50.50% -22.94% -28.13%
Quarterly Report Q2 8-K 2023-06-30 43.42% 2.28% -6.30%
Quarterly Report Q1 8-K 2023-03-31 -1.62% -0.41% -22.72%
Quarterly Report Q4 8-K 2022-12-31 5.66% -0.43% -13.64%
Quarterly Report Q3 8-K 2022-09-30 -53.03% -50.45% -56.73%
Quarterly Report Q2 8-K 2022-06-30 -37.83% -61.01% -65.02%
Quarterly Report Q1 8-K 2022-03-31 -48.55% -178.66% -180.45%
Quarterly Report Q4 8-K 2021-12-31 19.48% -167.25% -165.96%
Quarterly Report Q3 8-K 2021-09-30 39.93% -257.90% -254.29%
Quarterly Report Q2 8-K 2021-06-30 463.23% -76.28% -74.25%
Quarterly Report Q1 8-K 2021-03-31 445.57% -19.60% -17.09%
Quarterly Report Q4 8-K 2020-12-31 597.49% -10.18% -8.48%
Quarterly Report Q3 8-K 2020-09-30 1429.79% 30.07% 31.85%
Quarterly Report Q2 8-K 2020-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2020-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2019-09-30 0.00% 0.00% 0.00%